1-磷酸鞘氨醇对豚鼠心室肌动作电位和收缩力的影响

目的：研究1-磷酸鞘氨醇（S1P）对豚鼠心室肌动作电位（AP）和心肌收缩力（CF）的影响。方法：实验采用标准玻璃微电极细胞内记录技术记录心室肌细胞动作电位（AP）肌力换能器记录心肌收缩力（CF）。结果：①应用0．1μmol／LS1P后心室肌动作电位幅度（APA）和时程（APD）与应用SIP前比较差异无显著性,而应用1．0μmol／LS1P,10μmol／LS1P后心室肌动作电位的幅度（APA）与应用S1P前比较明显降低而动作电位的时程（APD）与应用S1P前比较明显延长（P〈0．01）。②应用1．0μmol／LS1P和10μmol／LSIP后心室肌的CF与给药前相比明显增强（P〈0．01）,应用0．1μmol／LS1P后心室肌的CF与给药前比较差异无显著性（P〉0．05）。而加入S1P特异性G蛋白耦联内皮细胞分化基因（EDG）受体阻断剂苏拉明后,S1P的上述作用与给药前比较差异无显著性（P〉0．05）。结论：S1P可以降低心室肌动作电位幅值延长动作电住时程,增加心室肌收缩力,并且是通过其特异性的G蛋白耦联内皮细胞分化基因（EDG）受体介导而产生这些作用,有一定的剂量依赖性.     

乙酰胆碱对豚鼠心房肌和心室肌的动作电位和收缩力的不同作用

实验采用标准玻璃微电极细胞内记录技术记录心肌细胞动作电位（action potential,AP）、肌力换能器记录心肌收缩力（force contraction,Fc）,研究乙酰胆碱（acetylcholine,ACh）对离体豚鼠心房肌、心室肌的作用。结果表明,10μmol/L ACh可缩短心房肌、心室肌动作电位的时程（action potential duration,APD）。心房肌APD在给药前后分别为208.57±36.05ms及101.78±14.41ms（n=6,P<0.01）,心室肌APD在给药前后分别为286.73±36.11ms及265.16±30.06 ms（n=6,P<0.01）。心房肌动作电位的幅度（action potential amplitude,APA）也降低,给药前后分别为88.00±9.35 mV及62.62±20.50 mV（n=6,P<0.01）,而心室肌APA无明显变化。ACh还降低心房肌、心室肌的收缩力,心房肌、心室肌Fc的抑制率分别为100％（n=6,P<0.01）和37.57±2.58％（n=6,P<0.01）。ACh对心房肌、心室肌APD和Fc的抑制作用在一定范围内（1nmol/L～100μmol/L）随ACh浓度的增高而增强。用Scott法求出ACh对心房肌、心室肌APD缩短作用的KD值,分别为0.275和0.575μmol/L,对Fc抑制作用的KD值分别为0.135和0.676μmol/L。各浓度下ACh对心房肌效应与心室肌效应作组间t检验,从10nmol/L到0.1mmol/L均有显著的统计学差异。此外,10μmol/L阿托品及20mmol/L     

镉对豚鼠乳头肌动作电位的影响

目的:研究氯化镉(CdCl2)对正常豚鼠心室乳头肌细胞动作电位(AP)的影响。方法:用常规细胞内微电极方法记录乳头肌细胞AP。结果:在生理条件下,CdCl2可使APo期振幅(APA)和最大除极速率(Vmax)降低,动作电位时程(APD)缩短,且具有剂量依赖性。结论:CdCl2可使心室肌AP的APA、Vmax、APD发生改变,提示CdCl2有抑制Na 、Ca2 内流和激活K 外流作用。     

雌、孕激素联合应用对豚鼠心室乳头肌细胞动作电位及收缩力的影响

目的:观察不同浓度17β雌二醇(E2)与孕酮(P)联合运用时豚鼠心室乳头肌细胞动作电位及心肌收缩力的影响.方法:采用常规玻璃微电极技术记录豚鼠心室乳头肌细胞动作电位,生理二道记录仪与示波器连接记录收缩力.结果:①E2与P单独作用可使动作电位时程(APD90、APD)延长,APD20缩短,心肌收缩力降低,APA、Vmax降低.②不同浓度E2与P联合应用,P可加强E2的效应.结论:E2与P可能抑制Ca2 通道、K 通道、Na 通道,不同浓度E2与P联合应用,P可加强E2的效应,这种作用可能呈现浓度依赖性,提示在临床应用中加用孕激素应以低浓度为益.     

胆碱能N_1受体激动剂洛贝林对豚鼠心室乳头肌电生理及收缩力的影响

本实验观察了在存在M受体阻断剂阿托品(2μM)的情况下,胆碱能N_1受体激动剂洛贝林(lobeline)对儿茶酚胺耗竭的豚鼠心室乳头肌电活动及收缩力的影响。洛贝林(0.5—8μM)使动作电位时程(APD)显著延长,动作电位0期最大除极速率(V_(max))和动作电位幅值(APA)下降,心肌收缩力(FC)减弱,以及收缩峰值出现时间(time-to-Peak force,TTP)提前。N_1 受体阻断剂六甲双铵(hexamethonium,10μM)使洛贝林对APD的剂量-反应曲线平行右移。这些实验结果提示:在豚鼠心室肌可能存在胆碱能N受体。     

白藜芦醇甙对大鼠心室乳头状肌动作电位的影响及其离子机制(英文)

有研究表明白藜芦醇甙(polydatin)具有抗缺血性心律失常作用,但其电生理学机制尚未明了。本研究旨在应用细胞内记录和全细胞膜片钳方法,探讨白藜芦醇甙对大鼠心室乳头状肌动作电位的影响及其离子机制。结果显示:(1)白藜芦醇甙(50和100μmol/L)可剂量依赖性地缩短正常乳头状肌动作电位复极化50%时间(APD50)和90%时间(APD90)(P<0.01)。白藜芦醇甙对正常乳头状肌静息电位(resting potential,RP)、动作电位幅值(amplitude of action potential,APA)、超射值(overshoot,OS)和0期最大上升速度(Vmax)无影响(P>0.05)。(2)对部分去极化的乳头状肌,白藜芦醇甙(50μmol/L)不但缩短APD50和APD90,而且还降低动作电位OS、APA和Vmax(P<0.05)。(3)ATP敏感钾通道阻断剂格列本脲(10μmol/L)可部分阻断白藜芦醇甙(50μmol/L)的电生理效应。(4)一氧化氮合酶抑制剂L-NAME(1 mmol/L)对白藜芦醇甙的上述效应无影响。(5)白藜芦醇甙(25、50、75、100μmol/L)可浓度依...     

9-蒽羧酸对豚鼠心室肌动作电位和L型Ca电流的影响

目的 :研究 9 蒽羧酸 (9 AC)对豚鼠心室肌动作电位 (AP)和L型Ca电流 (ICa)的影响。方法 :电流钳配合制霉菌素膜穿孔方法记录心室肌动作电位 ,用全细胞式膜片钳 (Whole cellrecording)技术记录ICa。结果 :在低Cl-状态下 ,β肾上腺素能受体激动剂异丙肾上腺素 (ISO)可使动作电位时程 (APD)明显延长。 9 AC单独使用时对AP无作用 ,但在ISO的作用下 ,蛋白磷酸酶抑制剂 9 AC可使APD进一步延长 ,ISO和 9 AC的作用可被Ca2 通道阻断剂硝苯地平 (3μmol/L)所反转。电压箝实验发现 ,在 β 肾上腺素能受体激动剂ISO激发下 ,9 AC使ICa的幅度进一步增加。结论 :9 AC与ISO有协同作用。本文结果提示 9 AC敏感性蛋白磷酸酶参与Ca2 通道的调控过程。     

低镁和缺镁对离体豚鼠右心室肌单细胞动作电位的效应

取豚鼠右心室肌,在改良 Krebs 溶液灌注下,用微电极记录动作电位(AP)12只豚鼠72次心肌单细胞 AP 有关参数的平均值为:静息电位(RP)-76±9mV;动作电位振幅(APA)107±7mV;动作电位时程(APD)_(_30mv)为254±123ms;APD_(100)为312±133ms。当灌注液中镁离子浓度减低到0.6mol/L 时,72次 AP 的 APD_(_30mv)和APD_(100)分別为对照值的80.7%和83%;在无镁溶液中,改变更为显著,分别为对照值的70.9%和76.7%;RP 和 APA 则变化均不大。实验提示:低镁可使 APD 缩短,从而可能影响体表心电图 T 波的第3位相;此外,APD 的缩短意味着不应期相对缩短,这或许是低镁症时出现室性早搏的因素。     

镉对大鼠心室肌细胞动作及L-型钙电流的影响

目的:探讨镉(Cd)对大鼠心室肌细胞动作电位(AP)及L-型钙电流(ICa-L)影响。方法:用常规微电极和全细胞膜片钳技术记录心肌细胞动作电位和ICa-L。结果:①不同浓度的CdCl2可降低大鼠心肌细胞动作电位幅值(APA),缩短复极化时程(APD)。②不同浓度的CdCl2明显抑制大鼠心室肌细胞钙通道电流。结论:CdCl2抑制大鼠心室肌细胞动作电位和ICa-L,可能是Cd对心肌毒性的重要机制之一。     

葛根素对大鼠心室肌细胞动作电位的影响

目的:从电生理角度探讨葛根素抗心律失常的可能机制。方法:采用膜片钳技术记录大鼠心室肌细胞动作电位(AP)、转染的人胚胎肾细胞缓慢延迟整流钾电流(IKs),观察加药前、后葛根素对AP和IKs的影响。结果:0.01、0.1、1 mmol/L葛根素可浓度依赖性地延长动作电位时程,分别使APD50从(71.8±11.8)ms延长至(86.9±10.7)ms、(100.5±14.1)ms和(123.6±25.4)ms;使APD90从(164.6±21.4)ms延长至(188.3±11.5)ms、(221.6±25.7)ms和(278.7±38.2)ms(n=6,均P0.05),而对RMP、APA和APD20无显著影响。此外,0.01、0.1、1 mmol/L葛根素对IKs抑制率分别为(17.8±2.5)%、(40.4±1.9)%和(60.9±3.2)%(n=6,均P0.05)。结论:葛根素可能通过抑制IKs来延长动作电位时程,发挥抗心律失常作用。     

Role of the ASK1-SEK1-JNK1-HIPK1 signal in Daxx trafficking and ASK1 oligomerization

Overexpression of JNK binding domain inhibited glucose deprivation-induced JNK1 activation, relocalization of Daxx from the nucleus to the cytoplasm, and apoptosis signal-regulating kinase 1 (ASK1) oligomerization in human prostate adenocarcinoma DU-145 cells. However, SB203580, a p38 inhibitor, did not prevent relocalization of Daxx and oligomerization of ASK1 during glucose deprivation. Studies from in vivo labeling and immune complex kinase assay demonstrated that phosphorylation of Daxx occurred during glucose deprivation, and its phosphorylation was mediated through the ASK1-SEK1-JNK1-HIPK1 signal transduction pathway. Data from immunofluorescence staining and protein interaction assay suggest that phosphorylated Daxx may be translocated to the cytoplasm, bind to ASK1, and subsequently lead to ASK1 oligomerization. Mutation of Daxx Ser667 to Ala results in suppression of Daxx relocalization during glucose deprivation, suggesting that Ser667 residue plays an important role in the relocalization of Daxx. Unlike wild-type Daxx, a Daxx deletion mutant (amino acids 501-625) mainly localized to the cytoplasm, where it associated with ASK1, activated JNK1, and induced ASK1 oligomerization without glucose deprivation. Taken together, these results show that glucose deprivation activates the ASK1-SEK1-JNK1-HIPK1 pathway, and the activated HIPK1 is probably involved in the relocalization of Daxx from the nucleus to the cytoplasm. The relocalized Daxx may play an important role in glucose deprivation-induced ASK1 oligomerization.     

DEC1 and MIC-1

Comment on: Qian Y, et al. Proc Natl Acad Sci USA 2012; 109:11300-5.     

LINE-1编码蛋白L1-ORF1的原核表达纯化和多克隆抗体制备

目的: 制备具有肿瘤组织特异性表达的L1-ORF1蛋白多克隆抗体并进行初步应用研究。方法:采取基因工程表达方法制备L1-ORF1蛋白,免疫家兔制备多克隆抗体,间接ELISA检测抗体效价,Western blot和细胞免疫荧光方法检测抗体特异性,免疫检测验证其识别肿瘤细胞内L1-ORF1蛋白的特异性。结果:制备的抗L1-ORF1蛋白多克隆抗体具有很高的敏感性与特异性,免疫学检测表明该抗体不仅能检测出正常细胞中瞬时表达的L1-ORF1蛋白,而且可检测出肿瘤细胞中天然表达的L1-ORF1蛋白。结论:制备的多克隆抗体具有较高的敏感性与特异性,为以后该抗体的进一步应用奠定了基础。     

Antagonism between Cry1Ac1 and Cyt1A1 toxins of bacillus thuringiensis

Most strains of the insecticidal bacterium Bacillus thuringiensis have a combination of different protoxins in their parasporal crystals. Some of the combinations clearly interact synergistically, like the toxins present in B. thuringiensis subsp. israelensis. In this paper we describe a novel joint activity of toxins from different strains of B. thuringiensis. In vitro bioassays in which we used pure, trypsin-activated Cry1Ac1 proteins from B. thuringiensis subsp. kurstaki, Cyt1A1 from B. thuringiensis subsp. israelensis, and Trichoplusia ni BTI-Tn5B1-4 cells revealed contrasting susceptibility characteristics. The 50% lethal concentrations (LC50s) were estimated to be 4,967 of Cry1Ac1 per ml of medium and 11.69 ng of Cyt1A1 per ml of medium. When mixtures of these toxins in different proportions were assayed, eight different LC50s were obtained. All of these LC50s were significantly higher than the expected LC50s of the mixtures. In addition, a series of bioassays were performed with late first-instar larvae of the cabbage looper and pure Cry1Ac1 and Cyt1A1 crystals, as well as two different combinations of the two toxins. The estimated mean LC50 of Cry1Ac1 was 2.46 ng/cm2 of diet, while Cyt1A1 crystals exhibited no toxicity, even at very high concentrations. The estimated mean LC50s of Cry1Ac1 crystals were 15.69 and 19.05 ng per cm2 of diet when these crystals were mixed with 100 and 1,000 ng of Cyt1A1 crystals per cm2 of diet, respectively. These results indicate that there is clear antagonism between the two toxins both in vitro and in vivo. Other joint-action analyses corroborated these results. Although this is the second report of antagonism between B. thuringiensis toxins, our evidence is the first evidence of antagonism between toxins from different subspecies of B. thuringiensis (B. thuringiensis subsp. kurstaki and B. thuringiensis subsp. israelensis) detected both in vivo and in vitro. Some possible explanations for this relationship are discussed.     

Regulation of PCTAIRE1 protein stability by AKT1, LKB1 and BRCA1

PCTAIRE1, also known as CDK16, is a cyclin-dependent kinase that is regulated by cyclin Y. It is a member of the serine-threonine family of kinases and its functions have primarily been implicated in cellular processes like vesicular transport, neuronal growth and development, myogenesis, spermatogenesis and cell proliferation. However, as extensive studies on PCTAIRE1 have not yet been conducted, the signaling pathways for this kinase involved in governing many cellular processes are yet to be elucidated in detail. Here, we report the association of PCTAIRE1 with important cellular proteins involved in major cell signaling pathways, especially cell proliferation. In particular, here we show that PCTAIRE1 interacts with AKT1, a key player of the PI3K signaling pathway that is responsible for promoting cell survival and proliferation. Our studies show that PCTAIRE1 is a substrate of AKT1 that gets stabilized by it. Further, we show that PCTAIRE1 also interacts with and is degraded by LKB1, a kinase that is known to suppress cellular proliferation and also regulate cellular energy metabolism. Moreover, our results show that PCTAIRE1 is also degraded by BRCA1, a well-known tumor suppressor. Together, our studies highlight the regulation of PCTAIRE1 by key players of the major cell signaling pathways involved in regulating cell proliferation, and therefore, provide crucial links that could be explored further to elucidate the mechanistic role of PCTAIRE1 in cell proliferation and tumorigenesis.     

Antagonism between Cry1Ac1 and Cyt1A1 Toxins of Bacillus thuringiensis

Most strains of the insecticidal bacterium Bacillus thuringiensis have a combination of different protoxins in their parasporal crystals. Some of the combinations clearly interact synergistically, like the toxins present in B. thuringiensis subsp. israelensis. In this paper we describe a novel joint activity of toxins from different strains of B. thuringiensis. In vitro bioassays in which we used pure, trypsin-activated Cry1Ac1 proteins from B. thuringiensis subsp. kurstaki, Cyt1A1 from B. thuringiensis subsp. israelensis, and Trichoplusia ni BTI-Tn5B1-4 cells revealed contrasting susceptibility characteristics. The 50% lethal concentrations (LC₅₀s) were estimated to be 4,967 of Cry1Ac1 per ml of medium and 11.69 ng of Cyt1A1 per ml of medium. When mixtures of these toxins in different proportions were assayed, eight different LC₅₀s were obtained. All of these LC₅₀s were significantly higher than the expected LC₅₀s of the mixtures. In addition, a series of bioassays were performed with late first-instar larvae of the cabbage looper and pure Cry1Ac1 and Cyt1A1 crystals, as well as two different combinations of the two toxins. The estimated mean LC₅₀ of Cry1Ac1 was 2.46 ng/cm² of diet, while Cyt1A1 crystals exhibited no toxicity, even at very high concentrations. The estimated mean LC₅₀s of Cry1Ac1 crystals were 15.69 and 19.05 ng per cm² of diet when these crystals were mixed with 100 and 1,000 ng of Cyt1A1 crystals per cm² of diet, respectively. These results indicate that there is clear antagonism between the two toxins both in vitro and in vivo. Other joint-action analyses corroborated these results. Although this is the second report of antagonism between B. thuringiensis toxins, our evidence is the first evidence of antagonism between toxins from different subspecies of B. thuringiensis (B. thuringiensis subsp. kurstaki and B. thuringiensis subsp. israelensis) detected both in vivo and in vitro. Some possible explanations for this relationship are discussed.     

Generation of 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-) mouse line

Human/rodent CYP1A1 and CYP1A2 orthologs are well known to exhibit species-specific differences in substrate preferences and rates of metabolism. This lab previously characterized a BAC-transgenic mouse carrying the human CYP1A1_CYP1A2 locus; in this line, human dioxin-inducible CYP1A1 and basal vs dioxin-inducible CYP1A2 have been shown to be expressed normally (with regard to mRNAs, proteins and three enzyme activities) in every one of nine mouse tissues studied. The mouse Cyp1a1 and Cyp1a2 genes are oriented head-to-head and share a bidirectional promoter region of 13,954 bp. Using Cre recombinase and loxP sites inserted 3' of the stop codons of both genes, we show here a successful interchromosomal excision of 26,173 bp that ablated both genes on the same allele. The Cyp1a1/1a2(-) double-knockout allele was bred with the "humanized" line; the final product is the hCYP1A1_1A2_Cyp1a1/1a2(-/-) line on a theoretically >99.8% C57BL/6J genetic background-having both human genes replacing the mouse orthologs. This line will be valuable for human risk assessment studies involving any environmental toxicant or drug that is a substrate for CYP1A1 or CYP1A2.     

Isolation and Characterization of Ubiquitin-activating Enzyme E1-domain Containing 1, UBE1DC1

Ubiquitin and other ubiquitin-like proteins play important roles in post-translational modification. They are phylogenetically well-conserved in eukaryotes. Activated by other proteins, ubiquitin and ubiquitin-like proteins can covalently modify target proteins. The enzymes responsible for the activation of this modification have been known to include UBA1, SAE2, UBA3, SAE1 and ULA1. Here we report a new ubiquitin activating enzyme like cDNA, named ubiquitin activating enzyme E1-domain containing 1 (UBE1DC1), whose cDNA is 2654 base pairs in length and contains an open reading frame encoding 404 amino acids. The UBE1DC1 gene consists of 12 exons and is located at human chromosome 3q22. The result of RT-PCR showed that UBE1DC1 is expressed in most of human tissues. These two authors contributed equally to this paper. The nucleotide sequence reported in this paper has been submitted to GenBank under accession number AY253672.